VITRAKVI 100 mg Capsule, hard

Licence status
Authorised: 19/09/2019
Active substances
LAROTRECTINIB SULFATE, LAROTRECTINIB
Dosage Form
Capsule, hard
Licence number
EU/1/19/1385/002
Licence holder
Bayer AG

Product documents

Licence information

ATC code
L01XE Protein kinase inhibitors
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/09/2019